Direct effects of methamphetamine on hypertrophy and microtubules in cultured adult rat ventricular myocytes.
Morphological alterations occasionally found in the myocardium of methamphetamine (MAP) abusers include hypertrophy, atrophy, disarrangement of myofibrils and fibrosis. These cardiac alterations have been thought to be due to an indirect action of MAP via catecholamines released by MAP administration. However, the direct effect of MAP on cardiomyocytes is not clear. In previous studies, we showed that cell size of isolated adult rat ventricular cardiomyocytes (ARCs) exposed to MAP was larger than that of untreated cells in culture supplemented with 10% fetal calf serum (FCS). In this study, to determine further the direct effect of MAP on cardiomyocytes, cultured ARCs were exposed to 0.05, 0.1 and 0.5 mM MAP for 7 days in culture medium without FCS following 6-day normal culture in medium containing FCS. Myocyte size was measured and microtubular (MT) structures which were associated with functional disorder of hearts were immunohistochemically observed using confocal microscopy. The size in treated ARCs significantly increased time- and dose-dependently as compared with untreated cells, but it decreased 7 days after exposure to 0.5 mM MAP. The increases in cell size, however, were lower than that in serum-supplemented cultures. MT structures in intact ARCs appeared as a filamentous network throughout the cytoplasm and around the nucleus. MAP exposure for 3 days promoted MT assembly, but in 7-day treated cells, MT and actin structures were injured. These results suggested that MAP directly induced cellular hypertrophy and might lead to cardiac functional disorder.
Maeno
Y
Y
Department of Legal Medicine, Nagoya City University Medical School, Kawasumi 1, Mizuho-ku, 467-8601, Nagoya, Japan. maenoyo@sunprom.med.nagoya-cu.ac.jp
Iwasa
M
M
Inoue
H
H
Koyama
H
H
Matoba
R
R
Nagao
M
M
D019969:Amphetamine-Related Disorders / Q000150:complications*; D000818:Animals; D006332:Cardiomegaly / Q000139:chemically induced* / Q000473:pathology*; D018929:Cell Culture Techniques / Q000379:methods; D002478:Cells, Cultured; D003470:Culture Media; D004305:Dose-Response Relationship, Drug; D006352:Heart Ventricles / Q000187:drug effects* / Q000648:ultrastructure*; D006984:Hypertrophy; D007150:Immunohistochemistry; D008297:Male; D008694:Methamphetamine / Q000009:adverse effects*; D018613:Microscopy, Confocal; D009206:Myocardium / Q000473:pathology* / Q000648:ultrastructure*; D051381:Rats; D017208:Rats, Wistar; D012710:Serum Albumin, Bovine; D013997:Time Factors
D003470:Culture Media; D012710:Serum Albumin, Bovine; D008694:Methamphetamine